Esketamine Treatment: A New Dawn for Treatment-Resistant Depression

Esketamine Treatment

n the landscape of mental health treatment, the emergence of esketamine (SPRAVATO®) represents one of the most significant advances in decades for individuals battling treatment-resistant depression (TRD). For the estimated one-third of people with major depressive disorder (MDD) who find little relief from traditional oral antidepressants, this treatment offers a new, rapid-acting pathway to potential recovery. […]

A New Hope for Treatment-Resistant Depression: Spravato Treatment at Brainiac Behavioral Health

For those who have tried multiple antidepressants without finding relief, the journey through depression can feel exhausting and hopeless. But there’s new hope on the horizon. Brainiac Behavioral Health in Orange County now offers Spravato (esketamine) treatment—an innovative, FDA-approved therapy that’s changing lives for people with treatment-resistant depression. What is Spravato? Spravato is a nasal […]